The abstract of this work was presented at the 2009 Annual Meeting of the International College of Geriatric Psychoneuropharmacology, Baltimore, MD.
This research was supported by National Institute on Aging grants R21AG028754, K08AG029157-01A1, and 2P50AG005146-22A1, and by National Institute of Neurological Disorders and Stroke Grant R21NS060271-01 and grants from GlaxoSmithKline and the George and Cynthia Mitchell Fund. All authors report no conflicts of interest. Although funding for this study was partially obtained through a grant from GlaxoSmithKline, the authors had access to the data at all times and retain the data. Funding for the plasma lipids were obtained from NIH grants. All authors report no conflicts of interests with regard to GlaxoSmithKline or any other organization.